Phase I/II study of nivolumab with or without ipilimumab for treatment of recurrent small cell lung cancer (SCLC): CA209-032

ABSTRACT:

SUBMITTER: Taylor M 

PROVIDER: S-EPMC4649441 | biostudies-literature | 2015 Jan

REPOSITORIES: biostudies-literature